{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:05:53Z","timestamp":1792191953454,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.amjcard.2004.07.080","type":"journal-article","created":{"date-parts":[[2005,2,9]],"date-time":"2005-02-09T06:47:22Z","timestamp":1107931642000},"page":"1140-1146","source":"Crossref","is-referenced-by-count":200,"title":["Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors"],"prefix":"10.1016","volume":"94","author":[{"given":"Terry A.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2004.07.080_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200202143460721","article-title":"Cerivastatin and reports of fatal rhabdomyolysis","volume":"346","author":"Staffa","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.07.080_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-4274(02)00010-3","article-title":"Myopathy and rhabdomyolysis with lipid-lowering drugs","volume":"128","author":"Hodel","year":"2002","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.amjcard.2004.07.080_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00002018-200022060-00003","article-title":"HMG-CoA reductase inhibitors and myotoxicity","volume":"22","author":"Ucar","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.amjcard.2004.07.080_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1345\/aph.1A289","article-title":"FDA adverse event reports on statin-associated rhabdomyolysis","volume":"36","author":"Omar","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2004.07.080_bib5","first-page":"339","article-title":"Simvastatin-diltiazem drug interaction resulting in rhabdomyolysis and hepatitis","volume":"94","author":"Kanathur","year":"2001","journal-title":"Tenn Med"},{"key":"10.1016\/j.amjcard.2004.07.080_bib6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1345\/aph.1A481","article-title":"Rhabdomyolysis with concurrent atorvastatin and diltiazem","volume":"36","author":"Lewin","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2004.07.080_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000046056","article-title":"Rhabdomyolysis associated with concurrent use of simvastatin and diltiazem","volume":"89","author":"Peces","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.amjcard.2004.07.080_bib8","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(05)78613-X","article-title":"Rhabdomyolysis due to interaction of simvastatin with mibefradil","volume":"351","author":"Schmassmann-Suhijar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2004.07.080_bib9","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1345\/aph.19039","article-title":"Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine","volume":"33","author":"Maltz","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2004.07.080_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0002-9343(99)00320-4","article-title":"Fatal rhabdomyolysis associated with simvastatin in a renal transplant patient","volume":"108","author":"Weise","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2004.07.080_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1345\/aph.10177","article-title":"Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin","volume":"35","author":"Lee","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2004.07.080_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/106002809703100710","article-title":"Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin","volume":"31","author":"Grunden","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2004.07.080_bib13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJM199509073331015","article-title":"Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole","volume":"333","author":"Lees","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.07.080_bib14","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/archderm.1996.03890340120028","article-title":"Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals (letter)","volume":"132","author":"Horn","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.amjcard.2004.07.080_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0022-5347(05)63967-5","article-title":"Rhabdomyolysis from cytochrome p-450 interaction of ketoconazole and simvastatin in prostate cancer","volume":"169","author":"Itakura","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.amjcard.2004.07.080_bib16","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1345\/aph.1C467","article-title":"Simvastatin-fluconazole causing rhabdomyolysis","volume":"37","author":"Shaukat","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2004.07.080_bib17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002030-200203080-00008","article-title":"Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047","volume":"16","author":"Fichtenbaum","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.amjcard.2004.07.080_bib18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1345\/aph.1C396","article-title":"Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction","volume":"37","author":"Sipe","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2004.07.080_bib19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1345\/aph.1A058","article-title":"Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole","volume":"36","author":"Maxa","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2004.07.080_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/108729103321655854","article-title":"Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir\/ritonavir in a patient with HIV","volume":"17","author":"Mah Ming","year":"2003","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.amjcard.2004.07.080_bib21","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/oxfordjournals.ndt.a027682","article-title":"Drug\u2013interaction-induced rhabdomyolysis","volume":"11","author":"Segaert","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjcard.2004.07.080_bib22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1067\/mcp.2000.110216","article-title":"Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin","volume":"68","author":"Lilja","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2004.07.080_bib23","series-title":"Method Validation for the Quantitation of Pravastatin and Its Biotransformation Products in Human Serum by Turbo Ion Spray LC\/MS\/MS. ABS Validation Report No. 98VDEM01.BR. Document Control No. 910067444","author":"Mulvana","year":"1998"},{"key":"10.1016\/j.amjcard.2004.07.080_bib24","series-title":"Method Validation for the Quantitation of Simvastatin and Simvastatin Acid in Human Serum by Turbo Ion Spray LC\/MS\/MS. ABS Validation Report No. 98VTCA01.BR. Document Control No. 910067446","author":"Alexander","year":"1998"},{"key":"10.1016\/j.amjcard.2004.07.080_bib25","unstructured":"Rosuvastatin (Crestor). US Prescribing Information. Available at: http:\/\/www.astrazeneca-us.com\/pilcrestor.pdf. Accessed September 23, 2004."},{"key":"10.1016\/j.amjcard.2004.07.080_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0140-6736(03)15396-2","article-title":"Rosuvastatin-warfarin drug interaction","volume":"363","author":"Barry","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2004.07.080_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0149-2918(03)80089-9","article-title":"An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers","volume":"25","author":"Martin","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2004.07.080_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0009-9236(02)17633-8","article-title":"Effect of itraconazole on the pharmacokinetics of rosuvastatin","volume":"73","author":"Cooper","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2004.07.080_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00228-003-0573-7","article-title":"The effect of erythromycin on the pharmacokinetics of rosuvastatin","volume":"59","author":"Cooper","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2004.07.080_bib30","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2004.07.080_bib31","unstructured":"Zocor tablets (simvastatin). In: Physicians' Desk Reference, 57th Ed. Montvale, NJ: Thomson Healthcare, 2003:2126\u20132131."},{"key":"10.1016\/j.amjcard.2004.07.080_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0009-9236(98)90151-5","article-title":"Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations","volume":"64","author":"Kantola","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2004.07.080_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0009-9236(98)90165-5","article-title":"Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole","volume":"63","author":"Neuvonen","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2004.07.080_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0009-9236(98)90023-6","article-title":"Effect of itraconazole on the pharmacokinetics of atorvastatin","volume":"64","author":"Kantola","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjcard.2004.07.080_bib35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1472-8206.1999.tb00344.x","article-title":"Mibefradil, a potent CYP3A inhibitor, does not alter pravastatin pharmacokinetics","volume":"13","author":"Becquemont","year":"1999","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2004.07.080_bib36","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/01.CIR.0000017634.00171.24","article-title":"Safety and tolerability of pravastatin in long-term clinical trials: Prospective Pravastatin Pooling (PPP) project","volume":"105","author":"Pfeffer","year":"2002","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914904011634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914904011634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T21:30:42Z","timestamp":1548797442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914904011634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0002914904011634"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2004.07.080","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}